Business

DECN Enters Exciting New Phase After High Court Hearing, Long Running Legal Battles With Johnson & Johnson Are Nearing A Positive Ending

DECN Enters Exciting New Phase After High Court Hearing, Long Running Legal Battles With Johnson & Johnson Are Nearing A Positive Ending.

articleDecision Diagnostics CorpOctober 24, 20194/company/decision-diagnostics/news/decn-enters-exciting-new-phase-after-high-court-hearing-long-running-legal-battles-with-johnson-and-johnson-are-nearing-a-positive-ending
DECN Enters Exciting New Phase After High Court Hearing, Long Running Legal Battles With Johnson & Johnson Are Nearing A Positive Ending

About this update from Decision Diagnostics Corp

[{"type":"text","content":"Company's Confidence Grows On The Back Of Recent Rulings And Court Room Events Strengthening An Already Strong Case With Huge Settlement Potential LOS ANGELES, CA / ACCESSWIRE / October 24, 2019 / Decision Diagnostics Corp. (OTC PINK:DECN) is a 17-year old, diabetes-focused bio-technology development firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for the GenUltimate! ("Sunshine") diabetes test strip, the GenSure! ("Feather") diabetes test strip for International markets, and its GenChoice! ("Ladybug") test strip now in FDA 510(k) prosecution. The company also markets its PetSure! test strip for the diabetic testing of dogs and cats, a diagnostic specifically designed to run on the market leading Zoetis Alpha Trak meter system and the GenUltimate! 4Pets Test strip and Avantage! meter a proprietary testing product for dogs, cats and horses, and the panacea GenUltimate! TBG ("Dragonfly") diabetes testing system, now awaiting a clinical trial slot in Korea, expected in November 2019.DECN announces today that on October 2, 2019 its lawyers from the firm of Fox Rothschild, argued the most important case in the company's history in front of a three judge panel in the Court of Appeals for the Federal Circuit (the patent dispute court). Opposing the company in front of the three judges was lawyers hired for this matter by long time antagonist Johnson & Johnson. This hearing marked the third time DECN and J&J did battle in this high court. DECN emerged totally victorious in the two previous cases previously heard in this court, one time earning a Precedential ruling where new law was made.Keith Berman, CEO of DECN commented, "Despite many delays and roadblocks, we finally secured our day in court. The Appeals Court for the Federal Circuit is the highest court in the U.S. system that hears all disputes and matters involving patents. The Federal Circuit sits just below the U.S. Supreme Court.Much of the misinformation and several of the rulings that the company has dealt with in the lower courts just do not hold purchase in the Federal Circuit. While we remain extremely optimistic, and even though we have fought J&J tooth and nail for over 8 years, we are al...

More updates from Decision Diagnostics Corp